FIFARMA AND FEDEFARMA PARTICIPATE IN THE INTERNATIONAL CONGRESS OF PHARMACY 2017

Cancer-control

The International Congress of Pharmacy 2017 and the Central America and Dominican Republic  regional Meeting of Health Authorities, Academy and Pharmaceutical Industry took place in San Jose, Costa Rica from August 7-11.

FIFARMA and FEDEFARMA representatives were invited to speak at the Congress and to participate in the Regulatory Workshop held on August 9. The workshop took place to
assess the Central American Technical Regulations, “Reglamentos Técnicos Centro Americanos” (RTCAs), in place in the region as part of the economic union process.

The Congress was organized by the University of Costa Rica’s Pharmacy Faculty, an entity committed to the health of Costa Rica’s population through training of pharmaceutical professionals and quality assurance and rational use of medicines through research and social action. Additional support was provided by members of the organizing committee, including Costa Rica’s Ministry of Health, the Council of Ministers of Health of Central America, and the Dominican Republic (COMISCA), the Costa Rica College of Pharmacists, and others from the pharmaceutical industry. The Congress welcomed 480 attendees, including 120 healthcare professionals and health authorities, academia and international organization representatives from Guatemala, El Salvador, Honduras, Nicaragua, Costa Rica, Belize, Dominican Republic, Mexico, Germany, United States, and Sweden.

The Congress agenda was divided into four themes:
• Good Regulatory Practices
• Pharmacovigilance
• Clinical Research
• Innovation, Development, and Biotechnology

By Annabelle Castro (ROCHE)

CANCER CONTROL, ACCESS, AND INEQUALITY IN LATIN AMERICA: A TALE OF LIGHT AND SHADOW

Cancer-control

Cancer currently accounts for 19% of deaths in Latin America. The number of deaths is expected to double by 2035 (106% increase), partly due to inequalities in access to cancer care and treatment – demonstrating the urgency of this growing issue for Latin American governments.

The “Cancer Control, Access and Inequality in Latin America” report developed by The Economist Intelligence Unit and sponsored by Roche describes the current cancer situation in 12 countries in Central and South America and shows how each is battling the growing disease burden.
The report is based on the Latin America Cancer Control Scorecard (LACCS), which assesses policies and programs designed to reduce inequality in cancer-care access in 12 Latin American countries.
Key takeaways include:

• Older cancer treatments are largely available in the 12 assessed countries, but new or novel treatments are rarely in country formularies. For example, no novel lung therapies are provided by the countries included in the study.
• 4.6% of GDP is the average government spending on health in the countries examined in the study (OECD average: 7.7%). Budgets, personnel, equipment, and other resources for cancer control will have to be bolstered to meet current and future needs.
• Inequalities in access to cancer care are a major problem. Access is worse for those unable to afford private insurance or to obtain social security-based insurance through their employment.
• Cancer control in rural areas remains a concern. Specialist human resources and equipment are concentrated in urban areas, making diagnosis less likely and adding travel expenses to already significant treatment costs.
Policymakers will need to tackle these inequalities to ensure continued progress in cancer control.
Find the full report and infographic at the link below: http://www.eiuperspectives.economist.com/LACCS

By Luciano Zylberberg (ROCHE)